Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
02 April 2019 | Story Valentino Ndaba | Photo Charl Devenish
Accounting Students
Pictured are 8 of the 64 UFS School of Accountancy students who form part of the 84.2% pass rate achievers.

Students from the University of the Free State (UFS) School of Accountancy achieved a 84.2% pass rate compared to the national average of 76.2% during the Initial Test of Competence (ITC) examination facilitated by the South African Institute of Chartered Accountants (SAICA).

A total of 64 out of 76 UFS students who attempted the ITC for the first time were successful in the examination. The ITC is known for its challenging nature.  Demographically, our African black students outperformed the 62.1% national pass rate by attaining an impressive 80.6%.

Collective congratulations

Prof Hentie van Wyk, Programme Director at the school, attributed diligence for the high pass rate. “This is due to our student-centred teaching module that was introduced four years ago and committed academic staff of the School of Accountancy from the first to the fourth year.”

Further future surge expected

“With the coming June 2019 ITC sitting, our pass rate for 2019 will most probably be more than 90%. Our three-year rolling average for 2015-2017, 2016-2018 and 2017-2019 were 83%, 86% and 90% respectively. Hopefully we can maintain the upward curve,” said Prof Van Wyk.

News Archive

Newly operational sequencing unit in genomics at UFS
2016-09-09

Description: Next Generation Sequencing  Tags: Next Generation Sequencing

Dr Martin Nyaga and his research assistant,
Tshidiso Mogotsi in the Next Generation
Sequencing Laboratory.
Photo: Charl Devenish

The Next Generation Sequencing (NGS) unit at the UFS was established as an interdisciplinary facility under the Directorate for Research Development, Faculty of Health Sciences and Faculty of Natural and Agricultural Sciences.

The aim of the NGS facility is to aid internal and external investigators undertaking studies on Deoxyribonucleic acid (DNA) sequencing, assembly and bioinformatics approaches using the more advanced Illumina MiSeq NGS platform.

The NGS unit became operational in 2016 and is managed by Dr Martin Nyaga and administered through the office of the Dean, Faculty of Health Sciences, under the leadership of Prof Gert Van Zyl. Dr Nyaga has vast experience in microbial genomics, having done his PhD in Molecular Virology.

He has worked and collaborated with globally recognised centres of excellence in Prokaryotic and Eukaryotic genomics, namely the J. Craig Venter Institute and the Laboratory of Viral Metagenomics, Rega Institute, among others.

The unit has undertaken several projects and successfully generated data on bacterial, viral and human genomes. Currently, work is ongoing on bacterial and fungal metagenomics studies through 16S rRNA sequencing.

In addition, the unit is also working on plasmid/insert sequencing and whole genome sequencing of animal and human rotaviruses. The unit has capacity to undertake other kinds of panels like the HLA, Pan-cancer and Tumor 15 sequencing, among others.

Several investigators from the UFS including but not limited to Prof Felicity Burt, Prof Wijnand Swart, Dr Frans O’Neil, Dr Trudi O'Neill, Dr Charlotte Boucher, Dr Marieka Gryzenhout and Dr Kamaldeen Baba are actively in collaboration with the NGS unit.

The unit has also invested in other specialised equipment such as the M220 Focused-ultrasonicator (Covaris), 2100 Bioanalyzer system (Agilent) and the real-time PCR cycler, the Rotor-Gene Q (Qiagen), which both the UFS and external investigators can use for their research.

Investigators working on molecular and related studies are encouraged to engage with Dr Nyaga on how they would like to approach their genomics projects at the UFS NGS unit. 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept